Conclusion: Everolimus can delay the progression of diabetic nephropathy.
结论：依维莫司能够延缓糖尿病肾病的进展。
2
Severe diarrhea occurred at a higher frequency in the combination group than in the everolimus group.
严重的腹泻在联合用药组的发生率高于依维莫司组。
3
Because of these safety concerns, a risk evaluation and mitigation strategy has been implemented to educate patients and clinicians regarding the safe use and risks of everolimus.